EFEmuella M. Flood

Emuella M. Flood

*This is an algorithmically generated author record based on publicly available information.

Emuella M. Flood has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Health-Related Quality of Life in Advanced Prostate Cancer and Its Treatments: Biochemical Failure and Metastatic Disease Populations

    by Oliver Sartor, Emuella Flood, Kathleen Beusterien, Josephine Park, Iain Webb, David MacLean, Bruce J.O. Wong, H. Mark Lin


  • Illustrating the impact of mild/moderate and severe haemophilia on health‐related quality of life: hypothesised conceptual models

    by Emuella Flood, Jennifer Pocoski, Lisa A. Michaels, Jill A. Bell, Satish Valluri, Rahul Sasanè

    Introduction/Aims: Haemophilia and its treatment have a significant impact on patients' lives. The study objectives were to understand the impacts of haemophilia and its treatment from the patient perspective and to inform the development of comprehensive health‐related quality‐of‐life (HRQL) conceptual models to illustrate these impacts.Methods: The study included two phases. Phase I involved a review of literature published from 1995 to 2010, qualitative analysis of six patient (N = 31) and three healthcare provider (N = 15) focus group transcripts, and interviews with two experts to inform draft conceptual models of mild/moderate and severe haemophilia. Phase II involved interviews with 20 haemophilia patients and qualitative analysis of transcripts to confirm the concepts and structure of the conceptual models.Results: The literature search resulted in 66 publications assessing HRQL, four of which were qualitative studies on the impact of haemophilia from the patient perspective. Results from Phase I indicated that acute bleeding events result in pain, swelling, bruising and restricted joint movement; repeated joint bleeds result in chronic symptoms, such as pain and arthropathy. Acute bleeds cause interruptions in daily activities and interfere with work/school. Patients have fears about having bleeds, which can affect their participation in activities, such as sports or crowded events. Patients also expressed feelings of depression, frustration, isolation and embarrassment. Results of Phase II corroborated findings from Phase I.Conclusions: The conceptual models illustrate the substantial impact of haemophilia and its treatments on patients' lives and can help inform clinical study design and the selection of endpoints to assess treatment benefit.


  • Patient‐reported experience of bleeding events in haemophilia

    by Emuella Flood, Jennifer Pocoski, Lisa A. Michaels, Anne McCoy, Kathleen Beusterien, Rahul Sasanè

    Background: Patients with haemophilia experience bleeds because of absent or reduced clotting factor. The study objective was to understand the bleeding experience from the patients' perspective.Materials and methods: Individuals with moderate/severe haemophilia participated in interviews and were asked to describe their most recent bleeding experience, including symptoms, signs of onset, impacts, when bleeding stopped and treatment effectiveness. Interview transcripts were analysed using a thematic analysis involving the coding of transcripts to identify key concepts and themes.Results: Twenty males [10 adults, mean age = 41 (19–52); 10 adolescents, mean age = 13 (12–17)] with moderate (n = 5) or severe (n = 15) haemophilia participated. Symptoms signalling bleed onset included pain, swelling, stiffness, tingling/numbness and/or warmth. Participants reported feeling anger and frustration due to the unpredictable nature, pain and inconvenience of the episode. Adults sometimes reported delaying treatment due to inconvenience or cost; adolescents generally treated right away. Reported bleed severity was influenced by pain level, speed of symptom progression, location, continued use of the affected area, recurrence in same location of recent bleed and treatment delay. Participants reported that it was ‘easy' to know when the bleed had stopped. Participants reported that symptoms might linger for days before they returned back to ‘normal'.Conclusions: This qualitative study details the substantial impact of an acute bleed from the patient perspective. Given that treatment was reported to be delayed in part due to inconvenience, more convenient treatment options could help reduce delays in treating bleeds and thereby minimise bleed‐related impacts. Clinical studies in haemophilia should include validated patient‐reported measurements of acute symptoms and bleed severity to comprehensively assess the bleeding event.


  • Open Access

    The patient experience with fatigue and content validity of a measure to assess fatigue severity: qualitative research in patients with ankylosing spondylitis (AS)

    by April N Naegeli, Emuella Flood, Jennifer Tucker, Jennifer Devlen, Emily Edson-Heredia

    Background: Ankylosing spondylitis (AS) is an autoimmune disorder characterized by inflammation of the spine and large joints. Fatigue is a common symptom that many AS patients find significantly impacts their health-related quality of life. The Worst Fatigue – Numeric Rating Scale (WF-NRS) assesses the severity of this symptom during the previous 24-hour period. The objective of this study was to perform qualitative research to support the development and content validity of the WF-NRS. Methods: Patients with AS were recruited from clinical sites in the U.S. for a qualitative study which first entailed concept elicitation interviews to gain understanding of the patients’ experience with AS and fatigue. Subsequently, cognitive debriefing interviews were undertaken to assess the understandability, clarity, and appropriateness from the patient’s perspective, of the content of a measure of fatigue severity. Results: Thirteen patients with AS participated in concept elicitation interviews and cognitive debriefing of the Brief Fatigue Inventory (BFI) fatigue severity subscale. The WF-NRS was developed from the worst fatigue item of the BFI as patients generally reported it to be understandable and covered an important concept, the completion instructions were modified, but the response scale remained as it was familiar and readily completed, and the recall period was appropriate. Conclusions: Patient responses resulted in the development of and supported the content validity of the WF-NRS. Further quantitative evaluation of the WF-NRS is warranted in order to assess its psychometric properties and confirm its usefulness as a clinical trial tool.


  • Demonstrating Measurement Equivalence of the Electronic and Paper Formats of the Urticaria Patient Daily Diary in Patients with Chronic Idiopathic Urticaria

    by Emuella M. Flood, James L. Zazzali, Jennifer Devlen

    The Urticaria Patient Daily Diary (UPDD), originally developed on paper, is a measure of key symptoms of chronic idiopathic urticaria (CIU). The development of the electronic version (eUPDD) involved moderate modifications to the appearance of the paper version. This study assessed the measurement equivalence of the electronic and paper versions of the UPDD in a sample of patients with CIU. This was a cross-over study of patients with moderate–severe CIU refractory to H1 antihistamines. Patients were randomized to either the eUPDD followed by the paper UPDD or vice versa. The UPDD includes morning and evening questions; both sets were administered together in this study. An hour-long filler task was given between paper and electronic administrations. Patients with stable symptoms between the two assessments were included in the analyses. Cohen’s kappa coefficients and intraclass correlation coefficients (ICC) were computed as applicable to assess equivalence. A total of 91 patients participated (mean age 43 years, 79.1 % female). Symptoms were stable between assessments for 67–74 (74–81 %) patients (varied by symptom). Kappa coefficients ranged from 0.82 to 1.00 for the individual UPDD items. For the Urticaria Activity Score (the sum of the ‘itch severity’ and ‘number of hives’ item scores) the ICC was 0.90 for the morning (Wilcoxon p = 0.331) and 0.95 for the evening (Wilcoxon p = 0.836). All test–retest statistics in this study were well above the accepted threshold, indicating excellent agreement between the two administration methods. Findings support the measurement equivalence of the electronic and paper versions of the UPDD to measure CIU symptoms.


  • A survey of children's preferences for influenza vaccine attributes

    by Emuella M. Flood, Kellie J. Ryan, Matthew D. Rousculp, Kathleen M. Beusterien, Stan L. Block, Matthew C. Hall, Parthiv J. Mahadevia


  • Children's Perceptions of Influenza Illness and Preferences for Influenza Vaccine

    by Emuella M. Flood, Stan L. Block, Matthew C. Hall, Matthew D. Rousculp, Victoria M. Divino, Seth L. Toback, Parthiv J. Mahadevia


  • Parent Preferences for Pediatric Influenza Vaccine Attributes

    by Emuella M. Flood, Kellie J. Ryan, Matthew D. Rousculp, Kathleen M. Beusterien, Victoria M. Divino, Stan L. Block, Matthew C. Hall, Parthiv J. Mahadevia

    Influenza vaccine is available as an intramuscular injection or an intranasal spray for eligible children. This study was conducted to examine parents’ preferences for influenza vaccine attributes and the attributes’ relative importance regarding the vaccination of their children. A quantitative Web survey was administered to 500 parents of children aged 2 to 12 years. The survey included general preference questions and conjoint (trade-off) questions. Parents most frequently selected efficacy, risk of temporary side effects, and physician recommendation as important vaccine attributes from a provided list (92%, 75%, and 59%, respectively). For attributes selected as important, parents rated the importance of the attribute; the highest mean importance ratings were given to efficacy, presence of mercury-containing preservative, and physician recommendation.The highest relative importance ratings in the conjoint section were given to efficacy and presence of mercury-containing preservative. Parental education on influenza vaccine efficacy and safety may help to improve pediatric vaccination rates.


  • Parents' decision-making regarding vaccinating their children against influenza: A web-based survey

    by Emuella M. Flood, Matthew D. Rousculp, Kellie J. Ryan, Kathleen M. Beusterien, Victoria M. Divino, Seth L. Toback, Medha Sasané, Stan L. Block, Matthew C. Hall, Parthiv J. Mahadevia


  • Patient and caregiver perspective on pediatric eosinophilic esophagitis and newly developed symptom questionnaires

    by Emuella M. Flood, Kathleen M. Beusterien, Mayur M. Amonkar, Cynthia H. Jurgensen, Odile E. Dewit, Lesley P. Kahl, Louis S. Matza

    Eosinophilic esophagitis (EE), a rare chronic inflammatory condition of the esophagus, is predominantly observed in children and is primarily manifested with feeding difficulties. To our knowledge, no self- or caregiver-reported questionnaires are available to assess pediatric EE symptoms and their impact as reported directly by children or their parents/caregivers. The objectives of this study were to characterize the symptoms and impact of EE among children as reported by patients and parents/caregivers and to assess the content validity of two newly developed pediatric eosinophilic esophagitis symptom questionnaires, one parent/caregiver-reported questionnaire for ages 2-7 years and one child-reported questionnaire for ages 8-17 years. The questionnaires were developed based on a review of the literature and clinical expert consultation. This cross-sectional study involving one-on-one interviews with patients and caregivers was conducted at an American Partnership for Eosinophilic Disorders conference. Parents of patients aged 2-7 years (n = 12) and patients aged 8-17 years (n = 16) were first asked about symptoms and their impact on everyday life, using open-ended questions. Participants then completed the appropriate symptom questionnaire and were asked to provide feedback on the relevance, comprehensiveness, and clarity of each item and other questionnaire issues (time to complete, length, format, etc.). All reported symptoms were enumerated, and the feedback on the symptom questionnaires was analyzed qualitatively. The majority of study participants were white (82%) and male (86%). The most frequently reported symptoms of 2-7-year olds were vomiting (92%), "reflux" (50%), dysphagia (25%), abdominal pain (25%), and trouble sleeping (25%). The 8-17-year group reported abdominal pain (56%), vomiting (31%), throat pain (25%), diarrhea (25%), and food getting stuck (25%). Symptoms and treatment were reported to have a major impact on daily life, particularly on school, after-school activities and social events, feeling frustrated regarding symptoms and treatment, and feeling "different". Overall, participants thought that the questionnaires were clear, relevant, and appropriate for symptom assessment. This study was based on a small and convenient sample of participants attending an EE conference and hence may not be representative of the general EE patient population. EE is associated with a range of symptoms that vary in terms of the type, frequency and severity across and within patients. The results provide adequate support for the content validity of the self- and caregiver-reported versions of the symptom-specific questionnaires. Minor modifications were made based on the feedback obtained. A psychometric evaluation of the revised questionnaires is needed next to assess the construct validity, reliability, and responsiveness of the measures.